Buy Rating Affirmed for Nemaura Medical on SugarBEAT Prospects and Market Expansion
Analysts Offer Insights on Healthcare Companies: Nemaura Medical (NMRD), Kineta (KA) and Regeneron (REGN)
Nemaura Medical Analyst Ratings
EF Hutton Adjusts Price Target on Nemaura Medical to $4 From $6, Maintains Buy Rating
Nemaura Medical Analyst Ratings
Analysts' Top Healthcare Picks: Nemaura Medical (NMRD), Atreca (BCEL)
EF Hutton Reiterates Buy on Nemaura Medical, Maintains $6 Price Target
EF Hutton Sticks to Their Buy Rating for Nemaura Medical (NMRD)
EF Hutton Maintains Buy on Nemaura Medical, Maintains $6 Price Target
HC Wainwright Adjusts Price Target on Nemaura Medical to $7 From $8, Keeps Buy Rating
H.C. Wainwright Keeps Their Buy Rating on Nemaura Medical (NMRD)
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Catalyst Pharma (CPRX) and Nemaura Medical (NMRD)
Nemaura Medical Analyst Ratings
HC Wainwright Adjusts Nemaura Medical's Price Target to $8 From $12, Reiterates Buy Rating
Apple To $185? Here Are 5 Other Price Target Changes For Friday
Nemaura Medical Price Target Cut to $8.00/Share From $12.00 by HC Wainwright & Co.
Nemaura Medical Is Maintained at Buy by HC Wainwright & Co.
No Data
No Data